Empirical Ventures, a specialist deeptech fund, has received an additional $13 million commitment from the British Business Bank, elevating the total support to $19.8 million. This significant investment, delivered through the bank's Regional Angels Programme, is set to accelerate Empirical's mission to fund the UK's most promising "venture scientists." The partnership aims to empower scientific founders who are translating fundamental research into globally impactful companies.
Championing the 'Venture Scientist'
At the core of Empirical Ventures' strategy is its "Venture Scientist" thesis, which posits that the most valuable companies of the next century will be built by deep domain experts. This model challenges the traditional focus on generalist entrepreneurs, instead championing founders who can navigate the complex boundary between scientific discovery and commercial application. The fund was specifically created to address the gap where exceptional scientists often lack investors who can comprehend their specialized work.
The firm was established to solve a critical problem in the investment landscape: the disconnect between brilliant scientific minds and the venture capital community. This new capital injection from the British Business Bank will enable Empirical Ventures to write high-conviction cheques for these technical founders across the United Kingdom. It provides the crucial early-stage backing needed to de-risk "hard science" ventures and prove their commercial viability.
A Strategic Partnership for UK Innovation
Mark Barry, Senior Investment Director at the British Business Bank, highlighted the strategic importance of this expanded commitment. He described the "Venture Scientist" as a powerful and untapped resource within the UK economy that is vital for future growth. By backing technical founders who are solving difficult problems, the partnership directly addresses a critical funding gap for innovative businesses.
A key objective of the collaboration is to foster innovation beyond the capital, ensuring the UK's brightest scientific minds receive support regardless of location. This partnership is designed to bridge the funding disparity for science-led businesses operating outside of London. The initiative ensures that researchers in cities like Bristol, Manchester, and Edinburgh have the resources to transform their work into category-defining global companies.
Fuelling DeepTech and Life Sciences
Dr. Johnathan Matlock, Co-Founder and General Partner at Empirical Ventures, stated that the greatest companies of the next three decades will be built by scientists. He noted that these founders have too often been underestimated or misunderstood by generalist investors who lack the necessary technical expertise. This $13 million commitment allows the fund to back these pioneering individuals with the conviction and resources they rightfully deserve.
Empirical Ventures provides patient capital through its unique SEIS & EIS Fund and Syndicate, giving scientists the financial fuel to leave the laboratory and build transformative technologies. The fund's focus spans deeptech and life sciences, including novel energy generation, advanced materials, and next-generation biotechnologies. This support is crucial for turning complex scientific breakthroughs into tangible products and services that can reshape the physical world.
This investment directly aligns with the UK government's 2026 Modern Industrial Strategy by unlocking the commercial potential of the nation's world-leading research base. By concentrating on deeptech and life sciences, Empirical Ventures is actively de-risking the "hard science" sector for other investors. This approach is expected to deliver outsized returns while also fostering the creation of high-skilled regional employment opportunities across the country.
The enhanced partnership between the British Business Bank and Empirical Ventures marks a pivotal moment for the UK's deeptech ecosystem. This substantial financial commitment not only validates the "Venture Scientist" investment thesis but also provides the necessary firepower to scale its impact nationwide. Ultimately, this collaboration signals a robust and strategic effort to cultivate a new generation of science-led companies poised to drive the future of the British economy.